Jacobs Levy Equity Management, Inc Seres Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$21.8 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.15 $301,514 - $697,049	324,209 New	324,209 $453,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $1.26 Million - $3.54 Million	-465,010 Reduced 49.46%	475,121 $1.63 Million
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $2.21 Million - $3.1 Million	-350,166 Reduced 27.14%	940,131 $6.69 Million
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $7.77 Million - $14.7 Million	1,290,297 New	1,290,297 $10.7 Million
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $530,588 - $861,036	-22,821 Closed	0 $0

Q3 2020 Nov 16, 2020	SELL	$3.74 - $28.74 $794,697 - $6.11 Million	-212,486 Reduced 90.3%	22,821 $646,000
Q2 2020 Aug 17, 2020	BUY	$3.04 - $6.2 $69,701 - $142,153	22,928 Added 10.8%	235,307 $1.12 Million
Q1 2020 May 15, 2020	SELL	$2.64 - $3.82 $319,484 - $462,284	-121,017 Reduced 36.3%	212,379 $758,000
Q4 2019 Feb 14, 2020	BUY	$2.99 - $4.42 $527,026 - $779,082	176,263 Added 112.17%	333,396 $1.15 Million
Q3 2019 Nov 14, 2019	BUY	$2.29 - $4.16 $194,313 - $352,988	84,853 Added 117.39%	157,133 $630,000
Q2 2019 Aug 13, 2019	SELL	$2.28 - $7.35 $282,954 - $912,157	-124,103 Reduced 63.19%	72,280 $233,000
Q1 2019 May 14, 2019	BUY	$4.83 - $7.21 $271,929 - $405,923	56,300 Added 40.19%	196,383 $1.35 Million
Q4 2018 Feb 14, 2019	BUY	$4.52 - $8.88 $44,295 - $87,024	9,800 Added 7.52%	140,083 $633,000
Q3 2018 Nov 14, 2018	SELL	$7.33 - $9.23 $67,443 - $84,925	-9,201 Reduced 6.6%	130,283 $989,000
Q2 2018 Aug 14, 2018	BUY	$6.91 - $9.55 $351,028 - $485,140	50,800 Added 57.28%	139,484 $1.2 Million
Q1 2018 May 15, 2018	SELL	$7.34 - $11.16 $3,919 - $5,959	-534 Reduced 0.6%	88,684 $651,000
Q4 2017 Feb 13, 2018	BUY	$9.15 - $12.64 $816,344 - $1.13 Million	89,218	89,218 $905,000

Others Institutions Holding MCRB

# of Institutions

100

Shares Held

62.7M

Call Options Held

36.9K

Put Options Held

476K

Flagship Pioneering Inc. Cambridge, MA

23.1M
Shares

$16.6 Million
1.17% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$4.91 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.73M
Shares

$4.85 Million
0.0% of portfolio
Hudson Bay Capital Management LP Greenwich, CT

5.43M
Shares

$3.91 Million
0.03% of portfolio
Geode Capital Management, LLC Boston, MA

2.13M
Shares

$1.54 Million
0.0% of portfolio

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account